Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |